University of Illinois at Chicago: Prostatic Neoplasms trials

The registry lists 12 Prostatic Neoplasms studies with University of Illinois at Chicago as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 3Phase 2 3Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GU-01: Glycyrrhizin in Prostate CancerRecruitingNCT06378346Phase 2
• Prostate Cancer Detection Screening MRI ProtocolCompletedNCT04175730Not applicableResults posted
• The Effects of Lycopene on High Risk Prostatic TissueCompletedNCT01443026Phase 2Results posted
• Smart Prostate Specific Antigen (PSA) Screening StudyCompletedNCT04782713Not applicable
• Engaging Newly Diagnosed Men About Cancer Treatment OptionsCompletedNCT02668276Not applicable
• Validation of Digital Morphometry for Cancer Risk in Benign Prostate BiopsiesCompletedNCT01594502
• Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate CancerCompletedNCT00765479Phase 2/3
• Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic HyperplasiaCompletedNCT00416390Not applicable
• Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate CancerCompletedNCT00416325Phase 1
• Lycopene in Preventing Prostate Cancer in Healthy ParticipantsStatus unknownNCT00322114Not applicable
• Lycopene in Preventing Prostate Cancer in Healthy ParticipantsCompletedNCT00093561Phase 1
• Lycopene In Preventing of Prostate CancerCompletedNCT00006078Phase 1